1250 Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: a case-control study with translational correlates

• Tingting Chen,
• Marie Hudson,
• Rejean Lapointe,
• Wilson H Miller,
• Pamela Thebault,
• Khashayar Esfahani,
• Jun Ding,
• Lucas A Salas,
• Steph A Pang,
• Manuel Flores Molina,
• Hsiang Chou,
• Christophe Goncalves,
• Paulo Nunes Filho,
• Sabin Filimon,
• Caroline M Michel,
• Sonia VDel Rincon

Affiliations

Tingting Chen

The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

Marie Hudson

Department of medicine, Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, Québec, Canada

Rejean Lapointe

2Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

Wilson H Miller

Division of Experimental Medicine, McGill University, Montreal, Québec, Canada

Pamela Thebault

2Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

Khashayar Esfahani

Division of Oncology, Department of Medicine, McGill University, Montreal, Quebec, Canada

Jun Ding

1 Medical Research Center, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People’s Hospital, Changzhou, Jiangsu, China

Lucas A Salas

7Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth Cancer Center, Lebanon, NH, USA

Steph A Pang

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada

Manuel Flores Molina

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada

Hsiang Chou

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada

Christophe Goncalves

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada

Paulo Nunes Filho

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada

Sabin Filimon

3McGill University Health Center, Division of Cardiology, Montreal, QC, Canada

Caroline M Michel

6Sir Mortimer B. Davis Jewish General Hospital, Division of Cardiology, McGill University, Montreal, QC, Canada

Sonia VDel Rincon

1Lady Davis Institute and Segal Cancer Centre, Sir Mortimer B. Davis Jewish General Hospital, Departments of Medicine and Oncology, McGill University, Montreal, QC, Canada